FDA User Fees Climb As Submission Projections Fall, Calculation Adjusted
This article was originally published in The Tan Sheet
Executive Summary
FDA announces new prescription and generic drug user fees, and changes its formula for PDUFA workload adjustments after an independent consultant found an element of the agency’s calculations was underestimating the complexity of its work in the drug review process.